All proceeds from the book sale will be donated to Sepsis Alliance and Donate Life America LEXINGTON, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid ...

T2 Biosystems has received FDA clearance to add the capability to detect another bacterial species, Acinetobacter baumannii, to its panel. T2 Biosystems is set to report its fourth-quarter financial ...

Data presented at the Innovation Session analyzed the detection time of both T2Bacteria and T2 sepsis panels. High Detection Rate: The T2Bacteria Panel showed broad coverage, detecting 77% of all ...

Shareholders might have noticed that T2 Biosystems, Inc. (NASDAQ:TTOO) filed its quarterly result this time last week. The early response was not positive, with shares down 6.8% to US$1.23 in the past ...

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the second ...

LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...

LEXINGTON, Mass., Oct. 14, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems (TTOO), Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced ...

T2 Biosystems Inc.’s stock fell 8.7% in premarket trades Friday as the developer of in vitro diagnostics products continued its pullback after ending Thursday’s session down 4.5% to snap a two-day ...

Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...

T2 Biosystems makes medical diagnostic testing equipment. The company reported a likely 60% in revenue in a preliminary third-quarter earnings report. T2 Biosystems also did a negative stock split to ...

LEXINGTON, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that CEO John Sperzel released a ...